Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02719028

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Golden Biotechnology Corporation (from the registry)
Registry
  • NCT NCT02719028
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02719028. Randomized; double masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2018-09-27 (actual). Results posted on 2019-12-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Condition
Hyperlipidemias
Intervention (Drug)
Antroquinonol
Intervention (Drug)
placebo
Lead sponsor
Golden Biotechnology Corporation (class: industry)

Record details

Record id
cardio:ct-nct02719028
Content hash
a6cd954d43e2614c07566aed391ede52caa8f6b280c837606c0f36f6ceacee20